Thursday, October 23, 2025

12:00 PM - 12:45 PM

---

Details

Australian life science companies typically achieve global success by partnering and/or integrating with companies from the USA or Europe. However, there is increasing opportunity for such companies to become fully global entities from our own backyard. With its rapid development and focus on investment in the biotech sector, China is no longer just a desirable market but is now considered a major originator of the science driving global developments. Combine the innovation and development capabilities of Australia and China, together with Singapore, Japan, Korea and Taiwan and you have the core of a biotech powerhub that could provide the world with major source of valuable new therapeutics. This session will hear from four Australian companies who have successfully embraced this path, along with the global perspective from one of the world’s oldest pharma companies, Merck KGaA.

---

Speaker